Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5795927',8'-dihydroaigialospirolMeSH

  structure in first source

• C5734247'-desmethylkealiiquinoneMeSH

  cytotoxic; synthesized from kealiiquinone from teucetta sponges; structure in first source

• C5713827((2E)-4(4,5-dihydro-3-methylene-2-oxo-5-furanyl)-3-methylbut-2-enyloxy)MeSH

  from Clausena excavata; structure in first source

• C5774347,12-bis(1-(2-(2-hydroxyethoxy)ethoxy)ethyl)-3,8,13,17-tetramethylporphyrin-2,18-dipropionatomanganeseMeSH

  a sonosensitizer; structure in first source

• C5797507,3'-di-(gamma, gamma-dimethylallyloxy)-5-hydroxy-4'-methoxyflavoneMeSH

  from Streptomyces sp. MA-12; structure in first source

• C5815487,4' -oxo-acetic acid daidzeinMeSH

  a phytoestrogen; structure in first source

• C5740397,7''-dimethoxyagastisflavoneMeSH

  isolated from the needles of Taxus × media cv. Hicksii; evaluated for its antiproliferative and antineoplastic effects in three human cancer cell lines

• C5736287,7'-(phenylmethylene)bis(3-methyl-6-(2-hydroxyphenyl)isoxazolo(4,5-b)pyridine-N-oxide)MeSH

  has antineoplastic activity; structure in first source

• C5736277,7'-(phenylmethylene)bis(3-methyl-6-phenylisoxazolo(4,5-b)pyridine-N-oxide)MeSH

  has antineoplastic activity; structure in first source

• C5790157,7'-dioxo-9,9'-epoxylignaneMeSH

  structure in first source

• C5767047,7-ethylenedioxy-bicyclo(2,2,1)-hepta-2,5-dieneMeSH

  structure in first source

• C5746657,8,3'-trihydroxyflavoneMeSH

  a potent small molecule TrkB receptor agonist that protects spiral ganglion neurons from degeneration both in vitro and in vivo

• D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideMeSH

  7,8,8a,9a-Tetrahydrobenzo(10,11)chryseno (3,4-b)oxirene-7,8-diol. A benzopyrene derivative with carcinogenic and mutagenic activity.

• C5823877,8-dimethoxy-3,4-methylenedioxy-phenanthrene-1-carboxylic acidMeSH

  an antibacterial denitroaristolochic acid derivative from the tubers of Stephania succifera; structure in first source

• C5768427,8-methylenedioxylycoctonineMeSH

  alkaloid from tall larkspur (Delphinium spp.), toxic to cattle; structure in first source

• C5679467,8-seco-7,8-oxacassa-13,15-diene-7,17-diolMeSH

  from Acacia schaffneri; structure in first source led to the isolation of the new diterpenoid

• C5817517-((4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)thio)-4-methyl-2H-chromen-2-oneMeSH

  structure in first source

• C5844497-((4-hydroxy-1,2,4a,5-tetramethyl-6-oxo-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl)methoxy)chromen-2-oneMeSH

  inhibits Rho-associated kinase 2; isolated from Ferula assafoetida; structure in first source

• C5851757-((5-nitrofuran-2-yl)methoxy)-3H-phenoxazin-3-oneMeSH

  structure in first source

• C5853487-((5-nitrothiophen-2-yl)methoxy)-3H-phenoxazin-3-oneMeSH

  for detection of nitroreductase; structure in first source

• C5829317-(1,1-dimethylheptyl)-5-hydroxy-3-(2-hydroxybenzyl)-2H-chromen-2-oneMeSH

  a GPR55 antagonist; structure in first source

• C5829307-(1,1-dimethyloctyl)-5-hydroxy-3-(2-hydroxybenzyl)-2H-chromen-2-oneMeSH

  a GPR55 antagonist; structure in first source

• C5684337-(1-hydroxy-1-methyl-3-(thien-3-yl)propyl)-6,14-ethanotetrahydrooripavineMeSH

  structure in first source

• C5763517-(1-vinyl)-tetradecahydro-1,4a-dimethylphenanthrene-7,8a-carbolactone-1-carboxylic acidMeSH

  has antispasmodic activity; isolated from Croton argyrophylloides; structure in first source

• C5833707-(2-(4-(2-fluoro-4-iodophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amineMeSH

  a radiotracer for PET imaging of adenosine 2A receptors; structure in first source

• C5689627-(2-aminopyrimidin-5-yl)-1-((1-cyclopropyl-2,2,2-trifluoroethyl)amino)-5H-pyrido(4,3-b)indole-4-carboxamideMeSH

  structure in first source

• C5868417-(2-furanyl)-1-(4-methoxybenzenesulfonyl)-6-azaindoleMeSH

  structure in first source

• C5751707-(2-oxohexyl)-11-hydroxy-6,12-dioxo-7,9(11),13-abietatrieneMeSH

  from Salvia austriaca; structure in first source

• C5806287-(2-oxohexyl)taxodioneMeSH

  isolated from Salvia austriaca; structure in first source

• C5616307-(3',7'-dimethyl-6'-oxo-2',7'-octadienyl)oxycoumarinMeSH

  a cytotoxic compound isolated from Zanthoxylum schinifolium; structure in first source

• C5831947-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)-6-(1-(4-(trifluoromethyl)cyclohexyl)-1H-1,2,4-triazol-5-yl)-4,7-dihydropyrazolo(1,5-a)pyrimidineMeSH

  structure in first source

• C5688587-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoic acid 6-(nitrooxy)hexyl amideMeSH

  a latanoprost prodrug and nitrix oxide donor; structure in first source

• C5598637-(3-(1-aminoethyl)pyrrolidin-1-yl)-9-cyclopropyl-6-fluoro-8-methoxyisothiazolo(5,4-b)quinoline-3,4(2H,9H)-dioneMeSH

  an antibacterial agent; structure in first source

• C5598647-(3-(2-aminopropan-2-yl)pyrrolidin-1-yl)-9-cyclopropyl-6-fluoro-8-methoxyisothiazolo(5,4-b)quinoline-3,4(2H,9H)-dioneMeSH

  an antibacterial agent; structure in first source

• C5686797-(3-(4-(2-fluoroethoxy)phenyl)propyl)-2-(furan-2-yl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amineMeSH

  an adenosine A2A receptor PET imaging agent; structure in first source

• C5602047-(3-amino-4-O-(mycarosyl)-2,3,6-trideoxyhexopyranosyl)daunorubicinoneMeSH

  binds serum albumin; structure in first source

• C5684227-(3-aminopyrrolo(3,4-c)pyrazol-5(2H,4H,6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acidMeSH

  structure in first source

• C5602117-(4-((3-fluorobenzyl)carbamoyl)-5-cyclopropyl-2-(4-fluorophenyl)-1H-imidazol-1-yl)-3,5-dihydroxyheptanoic acidMeSH

  structure in first source

• C5611057-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-oneMeSH

  a partial D2 and D3 agonist; structure in first source

• C5611047-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-oneMeSH

  a partial D2 and D3 agonist; structure in first source

• C5829267-(4-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)butoxy)-4-methyl-8-chloro-2H-chromen-2-oneMeSH

  structure in first source

• C5789807-(4-(diethylamino)butoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-oneMeSH

  has estrogenic activity; structure in first source

• C5739657-(4-benzyl-1-piperazinyl)-2(3H)-benzoxazolone methanesulfonateMeSH

  structure in first source

• C5682347-(4-methoxybenzyl)-4,5,6,7-tetrahydro-1,3-oxazepine-5,6-diolMeSH

  from the soil actinomycete Streptomyces albospinus; structure in first source

• C5795517-(4-methylsenecioyloxy)oplopa-3(14),8(10)-dien-2-oneMeSH

  inhibits nitric oxide production; isolated from Tussilago farfara; structure in first source

• C5810037-(7-amino-7-methyl-5-azaspiro(2.4)hept-5-yl)-6-fluoro-1-(2-fluorocyclopropyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acidMeSH

  structure in first source

• C5882957-(N-benzyl-N-methylamino)-2-oxo-2H-chromene-3-carboxylic acidMeSH

  a monocarboxylate transporter inhibitor; structure in first source

• C5769787-(O)-carboxymethyl daidzein N-t-Boc-hexylenediamine conjugateMeSH

  has antineoplastic activity

• C5862547-(benzyloxy)-6-(3-(dimethylamino)-propoxy)-5-hydroxy-2-phenyl-4H-chromen-4-oneMeSH

  structure in first source

• C5833757-(biphenyl-4-yl)-3,4,8,9-tetrahydro-2H-pyridazino(1,6-a)(1,3,5)triazin-2-imineMeSH

  structure in first source